This invention relates to a class of compounds having the general formula (I) which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

 
Web www.patentalert.com

< Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

> Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction

~ 00451